🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

El Clínico San Carlos, primer hospital que participa en un ensayo mundial de la OMS sobre la eficacia de los tratamientos actuales contra el #coronavirus #CoronavirusMadrid #CoronavirusEspaña #coronavirusEspana #QuedateEnCasa #YoMeQuedoEnCasa

Ayuda al Clínico a investigar con la iniciativa de donación para sus líneas de investigación en Covid-19. Y recuerda: en la ciencia está la respuesta! #somosclinico #donaidissc 👇👇👇 idissc.org/donacionCOVID1…

#COVID19 & Cancer: current & future challenges Join Stella Kyriakides for a live webinar on the impact of #coronavirus on cancer prevention & care as part of the European Week against Cancer at 10am CET on 28 May More details: ec.europa.eu/health/non_com… #EWAC2020 #EUCancerPlan

What are decision thresholds: Clinicians, guideline methodologists, systematic reviewers, and other researchers please provide your input through this survey! Click here: bit.ly/3bOloRB #guidelines #decisionmaking #healthresearch @hei_mcmaster Cochrane Canada GRADE Working Group

Your participation in this interesting survey should make future developments of recommendations easier:

Our systematic review and meta-analysis of EU studies published today shows that adherence to breast cancer guidelines is associated with better survival outcomes. Open access paper available: rdcu.be/b8dg3

Quality improvement and guideline creation need to be integrated! Great to see this first step - others follow shortly European Commission @ielluz @mwlangendam Elie Akl Amir Qaseem ZuleikaSazP Romina Brignardello +++

2/2 - bringing clarity to the confusion on #qualityassurance #qualityimprovement and guideline terminology and concepts! more to follow European Commission EU_ScienceHub Jeffrey Braithwaite @ielluz @mwlangendam Elie Akl Amir Qaseem ZuleikaSazP Romina Brignardello Thomas Piggott MD PhD Joerg J Meerpohl +++

Systematic reviews informing the European Commission recommendations on breast cancer screening recommendations are being gradually published. Conducted by CochraneIberoamerica @IIBSantPau and CIBERESP researchers using GRADE Working Group methods and GRADEproGDT software. See thread

The EU_ScienceHub is launching the 🇪🇺Initiative on Colorectal Cancer (ECICC) together with EU One Health. Are you a specialist, a patient or caregiver in this field? Join our ECICC working group! europa.eu/!Ww93jv - Application Deadline: 14 April 2021 MEPs Against Cancer Digestive Cancers Europe

1/ #contextual differences in #Tunisian #ADOLOPMENT of the #European #guidelines on #breastcancer #screening Lara Asma Ben Brahem & @othergreatcolleagues rdcu.be/ckAW8

3/ Check out how the #EtD in the #ADOLOPMENT module in GRADEproGDT can make your life easier when #adapting recommendations Holger Schünemann rdcu.be/ckAW8

4/ Check out the 3 possible approaches to sharing with the #adoloping panel information from the source #guideline GRADEproGDT Holger Schünemann rdcu.be/ckAW8

Participants needed for online survey! You are invited to participate in a research project, which aims to identify decision thresholds that could assist users of the GRADE frameworks in making judgements about health benefits and harms. surveymonkey.com/r/decisionthre…

Enhorabuena @ccaneloa!!!

Are you a specialist, a patient or caregiver in the field of cervical cancer screening and follow-up care join our working group by applying at europa.eu/!mVKvRF Deadline: 15 November 2023

Thanks to CIHR for funding this work on a crucial tool to assess bias in studies that together with the those on absolute treatment effects determine the balance of health benefits and harms of interventions. GIN Member Cochrane Canada Hector Pardo-Hernandez ZuleikaSazP

Institut de Recerca Sant Pau Adrienne Stevens Lawrence Mbuagbaw Uwe Siebert Feng Xie ROBVALU facilita la evaluación del riesgo de sesgo en los estudios sobre los valores, utilidades o la importancia de los desenlaces en el campo de la salud. Está diseñada para quienes trabajan con utilidades, evaluaciones de tecnologías, síntesis de evidencia y guías sanitarias.